New Antibiotic Tackles Drug-Resistant Gonorrhea in Trial

  • 📰 MedicineNet
  • ⏱ Reading Time:
  • 32 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 51%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

The first new antibiotic for gonorrhea — the second most common sexually transmitted disease — has shown promise in a clinical trial.

This new antibiotic, called zoliflodacin, was seen in the trial to cure uncomplicated gonorrhea infection as effectively as the current go-to, which is an injection of the antibiotic ceftriaxone along with one dose of“Zoliflodacin gives us a new tool in the treatment of gonorrhea, and if used wisely, a barrier against the further spread of resistant infections,” Dr.

Zoliflodacin treats gonorrhea in a new way. However, it's less effective at treating gonorrhea infection of the throat than it is in the genital or rectal areas,“Gonorrhea in the throat is probably going to be a major Achilles heel in our battle to control gonorrhea going forward,” said study co-author Dr. Jeanne Marrazzo, director of the U.S. National Institute of

There are more than 82 million new gonorrhea cases each year, according to the World Health Organization . Cases surged to more than 710,000 in 2021 in the United States, a 28% increase from 2017, according to the U.S. Centers for Disease Control and

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 575. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Congenital Syphilis Reaches ‘Dire Levels’ In U.S. Amid Antibiotic Shortage — Here’s What To KnowI am a senior reporter for the Forbes breaking news team, covering health and science from the London office. Previously I worked as a reporter for a trade publication covering big data and law and as a freelance journalist and policy analyst covering science, tech and health.
Source: ForbesTech - 🏆 318. / 59 Read more »